Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos JA, Santivañez S, Garcia HH, Nicoletti A; COHEMI Project Study Group, 2013. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2480.
-
2.
Del Brutto OH, Del Brutto VJ, 2012. Calcified neurocysticercosis among patients with primary headache. Cephalalgia 32: 250–254.
-
3.
Fujita M, Mahanty S, Zoqhbi SS, Ferraris Araneta MD, Hong J, Pike VW, Innis RB, Nash TE, 2013. PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema. PLoS ONE 8: e74052.
-
4.
Nash T, 2012. Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health 106: 275–279.
-
5.
Singla M, Singh P, Kaushal S, Bansal R, Singh G, 2007. Hippocampal sclerosis in association with neurocysticercosis. Epileptic Disord 9: 1–9.
-
6.
Rathore C, Thomas B, Kesavadas C, Radhakrishnan K, 2012. Calcified neurocysticercosis lesions and hippocampal sclerosis; potential dual pathology? Epilepsia 53: e60–e62.
-
7.
Bianchin MM, Velasco TR, Coimbra ER, Gargaro AC, Escorsi-Rosset SR, Wichert-Ana L, Terra VC, Alexandre V Jr, Araujo D Jr, dos Santos AC, Fernandes RM, Assirati JA Jr, Carlotti CG Jr, Leite JP, Takayanagui OM, Markowitsch HJ, Sakamoto AC, 2013. Cognitive and surgical outcome in mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis: a cohort study. PLoS ONE 8: e60949.
-
8.
Rathore C, Thomas B, Kesavadas C, Radhakrishnan K, 2013. Calcified neurocysticercosis lesions and antiepileptic drug-resistant epilepsy: a surgically remediable syndrome? Epilepsia 54: 1815–1822.
-
9.
Del Brutto OH, Santibañez R, Idrovo L, Rodriguez S, Díaz-Calderón E, Navas C, Gilman RH, Cuesta F, Mosquera A, Gonzalez AE, Tsang VC, Garcia HH, 2005. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46: 583–587.
-
10.
Del Brutto OH, Lama J, 2013. The importance of neurocysticercosis in stroke in rural areas of a developing country. Am J Trop Med Hyg 89: 374–375.
-
11.
Garcia HH, Del Brutto OH, 2003. Imaging findings in neurocysticercosis. Acta Trop 87: 71–78.
-
12.
Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, Evans CA, Gilman RH, Gonzalez AE, Loeb JA, Medina MT, Pietsch-Escueta S, Pretell EJ, Takayanagui OM, Theodore W, Tsang VC, Garcia HH, 2004. Calcific neurocysticercosis and epileptogenesis. Neurology 62: 1934–1938.
-
13.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummeings JL, Chertkow H, 2005. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53: 695–699.
-
14.
de Yébenes MJ, Otero A, Zunzunegui MV, Rodriguez-Laso A, Sanchez-Sanchez F, Del Ser T, 2013. Validation of a short cognitive tool for the screening of dementia in elderly people with low educational level. Int J Geriatr Psychiatry 18: 925–936.
-
15.
Scheltens Ph, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J, 1992. Atrophy of medical temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55: 967–972.
-
16.
Moyano LM, Saito M, Montano SM, 2014. Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. PLoS Negl Trop Dis 8: e2692.
-
17.
Kobayashi E, Guerreiro CA, Cendes F, 2001. Late onset epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis. Arq Neuropsiquiatr 59: 255–258.
-
18.
Chung CK, Lee SK, Chi JG, 1998. Temporal lobe epilepsy caused by intrahippocampal calcified cysticercus: a case report. J Korean Med Sci 13: 445–448.
-
19.
Singh G, Burneo JG, Sander W, 2013. From seizures to epilepsy and its substrates: neurocysticercosis. Epilepsia 54: 783–792.
-
20.
Bianchin MM, Velasco TR, Takayanagui OM, Sakamoto AC, 2006. Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored. Lancet Neurol 5: 20–21.
-
21.
Bianchin MM, Velasco TR, dos Santos AC, Sakamoto AC, 2012. On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship? Pathog Glob Health 106: 280–285.
-
22.
Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH; Cysticercosis Working Group in Peru, 2008. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 1099–1105.
-
23.
Kahn MS, Kranjac D, Alonzo CA, Haase JH, Cedillos RO, McLinden KA, Boehm GW, Chumley MJ, 2012. Prolonged elevation in hippocampal Aβ and cognitive deficit following repeated endotoxin exposure in the mouse. Behav Brain Res 229: 176–184.
-
24.
Bastos-Leite AJ, van Waesberghe JH, Oen AL, van der Flier WM, Scheltens P, Barkhof E, 2006. Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjects. AJNR Am J Neuroradiol 27: 2141–2145.
-
25.
Gómez F, Zunzunegui MV, Lord C, Alvarado B, García A, 2013. Applicability of the MoCA-S test in populations with little education in Colombia. Int J Geriatr Psychiatry 28: 813–820.
-
26.
Del Brutto OH, Gardener H, Del Brutto VJ, Maestre GE, Zambrano M, Montenegro JE, Wright CB, 2014. Edentulism associates with worse cognitive performance in community-dwelling elders in rural Ecuador: results of the Atahualpa Project. J Community Health doi:10.1007/s10900-014-9857-3.
-
27.
Terra-Bustamante VC, Coimbra ER, Rezek KO, Escorsi-Rosset SR, Guarnieri R, Dalmagro CL, Inuzuka LM, Bianchin MM, Wichert-Ana L, Alexandre V, Takayanagui ON, Araujo D, dos Santos AC, Carlotti CG, Walz R, Markowitsch HJ, Sakamoto AC, 2005. Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis. J Neurol Neurosurg Psychiatry 76: 1080–1083.
-
28.
Boutet C, Chupin M, Colliot O, Sarazin M, Mutlu G, Drier A, Pellot A, Dormont D, Lehéricy S; Alzheimer's Disease Neuroimaging Initiative, 2012. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease? Neuroradiology 54: 1321–1330.
-
29.
Garcia HH, Rodriguez S, Gilman RH, Gonzalez AE, Tsang VC, 2012. Neurocysticercosis: is serology useful in the absence of brain imaging? Trop Med Int Health 17: 1014–1018.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1630 | 1479 | 96 |
| Full Text Views | 422 | 15 | 2 |
| PDF Downloads | 137 | 12 | 0 |
Calcified Neurocysticercosis Associates with Hippocampal Atrophy: A Population-Based Study
Oscar H. Del Brutto
Oscar H. Del Brutto
School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador; Department of Neurological Sciences, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico; Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Community Center of the Atahualpa Project, Atahualpa, Ecuador; Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador; Center for Global Health, Tumbes and the Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
Search for other papers by Oscar H. Del Brutto in
Current site
Google Scholar
PubMed
Search for other papers by Oscar H. Del Brutto in
Current site
Google Scholar
PubMed
Perla Salgado
Perla Salgado
School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador; Department of Neurological Sciences, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico; Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Community Center of the Atahualpa Project, Atahualpa, Ecuador; Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador; Center for Global Health, Tumbes and the Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
Search for other papers by Perla Salgado in
Current site
Google Scholar
PubMed
Search for other papers by Perla Salgado in
Current site
Google Scholar
PubMed
Julio Lama
Julio Lama
School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador; Department of Neurological Sciences, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico; Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Community Center of the Atahualpa Project, Atahualpa, Ecuador; Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador; Center for Global Health, Tumbes and the Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
Search for other papers by Julio Lama in
Current site
Google Scholar
PubMed
Search for other papers by Julio Lama in
Current site
Google Scholar
PubMed
Victor J. Del Brutto
Victor J. Del Brutto
School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador; Department of Neurological Sciences, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico; Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Community Center of the Atahualpa Project, Atahualpa, Ecuador; Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador; Center for Global Health, Tumbes and the Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
Search for other papers by Victor J. Del Brutto in
Current site
Google Scholar
PubMed
Search for other papers by Victor J. Del Brutto in
Current site
Google Scholar
PubMed
Xavier Campos
Xavier Campos
School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador; Department of Neurological Sciences, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico; Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Community Center of the Atahualpa Project, Atahualpa, Ecuador; Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador; Center for Global Health, Tumbes and the Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
Search for other papers by Xavier Campos in
Current site
Google Scholar
PubMed
Search for other papers by Xavier Campos in
Current site
Google Scholar
PubMed
Mauricio Zambrano
Mauricio Zambrano
School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador; Department of Neurological Sciences, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico; Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Community Center of the Atahualpa Project, Atahualpa, Ecuador; Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador; Center for Global Health, Tumbes and the Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
Search for other papers by Mauricio Zambrano in
Current site
Google Scholar
PubMed
Search for other papers by Mauricio Zambrano in
Current site
Google Scholar
PubMed
Héctor H. García
Héctor H. García
School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador; Department of Neurological Sciences, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico; Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador; Community Center of the Atahualpa Project, Atahualpa, Ecuador; Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador; Center for Global Health, Tumbes and the Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
Search for other papers by Héctor H. García in
Current site
Google Scholar
PubMed
Search for other papers by Héctor H. García in
Current site
Google Scholar
PubMed
Calcified neurocysticercosis has been associated with hippocampal atrophy in patients with refractory epilepsy, but the relevance of this association in the population at large is unknown. We assessed calcified cysticerci and its association with hippocampal atrophy in elderly persons living in Atahualpa, an Ecuadorian village endemic for neurocysticercosis. All Atahualpa residents ≥ 60 years of age were invited to undergo computed tomography/magnetic resonance imaging for neurocysticercosis detection. Twenty-eight (11%) out of 248 enrolled persons had calcified cysticerci (case-patients) and were matched 1:1 by age, sex, and years of education to individuals without neurocysticercosis on computed tomography/magnetic resonance imaging (controls). Four case-patients and none of the controls had epilepsy (P = 0.134). Cognitive performance was similar across both groups. The Scheltens' medial temporal atrophy scale was used for hippocampal rating in case-patients and matched controls without neurocysticercosis. Mean score in the Scheltens' scale was higher in case-patients than in controls (P < 0.001). Atrophic hippocampi were noticed in 19 case-patients and five controls (P = 0.003). Atrophy was bilateral in 11 case-patients and unilateral in eight. All case-patients with unilateral hippocampal atrophy had at least one ipsilateral calcification. This study shows an association between calcified cysticerci and hippocampal atrophy and raises the possibility of an inflammation-mediated hippocampal damage as the responsible mechanism for these findings.
Author Notes
Financial support: This study was partially supported by Universidad Espíritu Santo – Ecuador, Guayaquil – Ecuador. HHG is supported by a Wellcome Trust International Senior Fellowship in Public Health and Tropical Medicine.
Authors' addresses: Oscar H. Del Brutto, School of Medicine, Universidad Espíritu Santo – Ecuador, Guayaquil, Ecuador, E-mail: oscardelbrutto@hotmail.com. Perla Salgado, Neuroimaging Unit, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico 22 DF, Mexico, E-mail: pmtsalgado@yahoo.com.mx. Julio Lama, Imaging Department, Hospital-Clínica Kennedy, Guayaquil, Ecuador, E-mail: julama54@hotmail.com. Victor J. Del Brutto and Mauricio Zambrano, Community Center of the Atahualpa Project, Atahualpa, Ecuador, E-mails: vjdelbrutto@gmail.com and zamaleon@hotmail.com. Xavier Campos, Outpatient Center North, Ecuadorian Institute of Social Security, Guayaquil, Ecuador, E-mail: xaviercampos63@hotmail.com. Héctor H. García, Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú, E-mail: hgarcia@jhsph.edu.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos JA, Santivañez S, Garcia HH, Nicoletti A; COHEMI Project Study Group, 2013. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2480.
-
2.
Del Brutto OH, Del Brutto VJ, 2012. Calcified neurocysticercosis among patients with primary headache. Cephalalgia 32: 250–254.
-
3.
Fujita M, Mahanty S, Zoqhbi SS, Ferraris Araneta MD, Hong J, Pike VW, Innis RB, Nash TE, 2013. PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema. PLoS ONE 8: e74052.
-
4.
Nash T, 2012. Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health 106: 275–279.
-
5.
Singla M, Singh P, Kaushal S, Bansal R, Singh G, 2007. Hippocampal sclerosis in association with neurocysticercosis. Epileptic Disord 9: 1–9.
-
6.
Rathore C, Thomas B, Kesavadas C, Radhakrishnan K, 2012. Calcified neurocysticercosis lesions and hippocampal sclerosis; potential dual pathology? Epilepsia 53: e60–e62.
-
7.
Bianchin MM, Velasco TR, Coimbra ER, Gargaro AC, Escorsi-Rosset SR, Wichert-Ana L, Terra VC, Alexandre V Jr, Araujo D Jr, dos Santos AC, Fernandes RM, Assirati JA Jr, Carlotti CG Jr, Leite JP, Takayanagui OM, Markowitsch HJ, Sakamoto AC, 2013. Cognitive and surgical outcome in mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis: a cohort study. PLoS ONE 8: e60949.
-
8.
Rathore C, Thomas B, Kesavadas C, Radhakrishnan K, 2013. Calcified neurocysticercosis lesions and antiepileptic drug-resistant epilepsy: a surgically remediable syndrome? Epilepsia 54: 1815–1822.
-
9.
Del Brutto OH, Santibañez R, Idrovo L, Rodriguez S, Díaz-Calderón E, Navas C, Gilman RH, Cuesta F, Mosquera A, Gonzalez AE, Tsang VC, Garcia HH, 2005. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46: 583–587.
-
10.
Del Brutto OH, Lama J, 2013. The importance of neurocysticercosis in stroke in rural areas of a developing country. Am J Trop Med Hyg 89: 374–375.
-
11.
Garcia HH, Del Brutto OH, 2003. Imaging findings in neurocysticercosis. Acta Trop 87: 71–78.
-
12.
Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, Evans CA, Gilman RH, Gonzalez AE, Loeb JA, Medina MT, Pietsch-Escueta S, Pretell EJ, Takayanagui OM, Theodore W, Tsang VC, Garcia HH, 2004. Calcific neurocysticercosis and epileptogenesis. Neurology 62: 1934–1938.
-
13.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummeings JL, Chertkow H, 2005. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53: 695–699.
-
14.
de Yébenes MJ, Otero A, Zunzunegui MV, Rodriguez-Laso A, Sanchez-Sanchez F, Del Ser T, 2013. Validation of a short cognitive tool for the screening of dementia in elderly people with low educational level. Int J Geriatr Psychiatry 18: 925–936.
-
15.
Scheltens Ph, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J, 1992. Atrophy of medical temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55: 967–972.
-
16.
Moyano LM, Saito M, Montano SM, 2014. Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. PLoS Negl Trop Dis 8: e2692.
-
17.
Kobayashi E, Guerreiro CA, Cendes F, 2001. Late onset epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis. Arq Neuropsiquiatr 59: 255–258.
-
18.
Chung CK, Lee SK, Chi JG, 1998. Temporal lobe epilepsy caused by intrahippocampal calcified cysticercus: a case report. J Korean Med Sci 13: 445–448.
-
19.
Singh G, Burneo JG, Sander W, 2013. From seizures to epilepsy and its substrates: neurocysticercosis. Epilepsia 54: 783–792.
-
20.
Bianchin MM, Velasco TR, Takayanagui OM, Sakamoto AC, 2006. Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored. Lancet Neurol 5: 20–21.
-
21.
Bianchin MM, Velasco TR, dos Santos AC, Sakamoto AC, 2012. On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship? Pathog Glob Health 106: 280–285.
-
22.
Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH; Cysticercosis Working Group in Peru, 2008. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 1099–1105.
-
23.
Kahn MS, Kranjac D, Alonzo CA, Haase JH, Cedillos RO, McLinden KA, Boehm GW, Chumley MJ, 2012. Prolonged elevation in hippocampal Aβ and cognitive deficit following repeated endotoxin exposure in the mouse. Behav Brain Res 229: 176–184.
-
24.
Bastos-Leite AJ, van Waesberghe JH, Oen AL, van der Flier WM, Scheltens P, Barkhof E, 2006. Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjects. AJNR Am J Neuroradiol 27: 2141–2145.
-
25.
Gómez F, Zunzunegui MV, Lord C, Alvarado B, García A, 2013. Applicability of the MoCA-S test in populations with little education in Colombia. Int J Geriatr Psychiatry 28: 813–820.
-
26.
Del Brutto OH, Gardener H, Del Brutto VJ, Maestre GE, Zambrano M, Montenegro JE, Wright CB, 2014. Edentulism associates with worse cognitive performance in community-dwelling elders in rural Ecuador: results of the Atahualpa Project. J Community Health doi:10.1007/s10900-014-9857-3.
-
27.
Terra-Bustamante VC, Coimbra ER, Rezek KO, Escorsi-Rosset SR, Guarnieri R, Dalmagro CL, Inuzuka LM, Bianchin MM, Wichert-Ana L, Alexandre V, Takayanagui ON, Araujo D, dos Santos AC, Carlotti CG, Walz R, Markowitsch HJ, Sakamoto AC, 2005. Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis. J Neurol Neurosurg Psychiatry 76: 1080–1083.
-
28.
Boutet C, Chupin M, Colliot O, Sarazin M, Mutlu G, Drier A, Pellot A, Dormont D, Lehéricy S; Alzheimer's Disease Neuroimaging Initiative, 2012. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease? Neuroradiology 54: 1321–1330.
-
29.
Garcia HH, Rodriguez S, Gilman RH, Gonzalez AE, Tsang VC, 2012. Neurocysticercosis: is serology useful in the absence of brain imaging? Trop Med Int Health 17: 1014–1018.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1630 | 1479 | 96 |
| Full Text Views | 422 | 15 | 2 |
| PDF Downloads | 137 | 12 | 0 |